Schizophrenia Journal Articles

• Choosing Medication Type for Opioid Use Disorder Patients Learn more about a proposed treatment rule that would help to optimally match these patients with medication type and reduce the risk of returning to regular opioid use.
  American Journal of Epidemiology, May 26, 2023
• Cumulative Environmental Risk and Schizotypy in Childhood This study investigated the association between 19 environmental risk exposures and three distinct profiles of schizotypy in middle childhood.
  Schizophrenia Bulletin, May 19, 2023
• COVID-19 Mortality After Vaccination in Severe Mentally Ill This study found that even after vaccination, patients with schizophrenia or other severe mental illnesses are more likely to die from COVID-19 infection than matched controls.
  Schizophrenia Bulletin, April 20, 2023
• Women with Schizophrenia-Spectrum Disorders After Menopause Menopause is an independent risk factor for relapse in women with schizophrenia spectrum disorders, according to this study, and antipsychotic effectiveness declines this age group as well.
  Schizophrenia Bulletin, March 20, 2023
• Psychosocial Interventions for Generalized Anxiety Disorder This paper summarizes recent studies on the benefits from exercise, different forms of CBT, and digital interventions for treatment of generalized anxiety disorder.
  Current Psychiatry, March 08, 2023
• Neuropsychiatric Symptoms After Stroke Patients and families may not realize certain psychiatric symptoms are stroke-related. Review the types of psychiatric symptoms associated with strokes in specific brain regions in this article.
  Current Psychiatry, March 01, 2023
• Med Check' Appointments: How to Minimize Your Malpractice Risk What factors should be considered for reducing the risk of malpractice related to brief "med checks"--short follow-up appointments for psychiatric outpatient medication management?
  Current Psychiatry, February 22, 2023
• Relapse After Dose Reduction of Antipsychotics in Schizophrenia What factors may contribute to the risk of psychotic relapse when considering dose reduction or discontinuation of antipsychotics in patients with chronic schizophrenia?
  Schizophrenia Bulletin, February 20, 2023
• Exercise Intervention in Individuals at High Risk for Psychosis Might a regimen of high-intensity exercise be a beneficial therapeutic tool for patients at clinical high risk for psychosis?
  Schizophrenia Bulletin, January 20, 2023
• Advances in the Gut Microbiome and Mood Disorders This review summarizes recent advances in our understanding of the role of the gut microbiome in mood disorders, including the use of psychobiotics for the treatment and prevention of these disorders.
  Current Opinion in Psychiatry, December 21, 2022
• tDCS to Improve Insight in Patients With Schizophrenia Transcranial direct current stimulation has been shown to be effective in relieving some symptoms of schizophrenia. Might it also improve insight in patients with schizophrenia?
  Schizophrenia Bulletin, December 20, 2022
• Voice-Hearing: A Phenomenology of Spiritual Voices How does the phenomenology of voice-hearing experiences in individuals with spiritualist and related beliefs, such as psychics and mediums, compare with voice-hearing in persons with psychosis?
  Schizophrenia Bulletin, November 14, 2022
• Schizophrenia Polygenic Risk and Childhood Adversity This meta-analysis found that risk genes for schizophrenia influence childhood adversities in psychosis, but this gene-environment interaction does not fully explain the relationship.
  Schizophrenia Bulletin, October 14, 2022
• Home-Based Transcranial DCS to Enhance Cognition in Stroke Is home-based, remotely supervised transcranial direct current stimulation feasible, safe, and effective for improving poststroke cognitive function in patients with chronic stroke?
  Stroke, October 13, 2022
• Intraoperative BP and Long-Term Neurodevelopment in Children What impact, if any, might intraoperative blood pressure measurements have on the long-term neurodevelopmental outcomes of children undergoing ambulatory surgery?
  Anesthesia & Analgesia, October 10, 2022
• Adaptive Changes to Antipsychotics: Avoiding the Consequences Review the mechanisms behind chronic dopamine D2R blockade by antipsychotics. How can we mitigate the adaptive changes that can contribute to both acute and chronic adverse effects?
  Current Psychiatry, October 05, 2022
• Polypharmacy and HRQoL Among Patients With Chronic Disease Does polypharmacy negatively impact the psychological domain of HRQoL as well as the physical domain among patients with chronic diseases?
  Preventing Chronic Disease, September 22, 2022
• Nonpsychiatric Indications for Antidepressants, Antipsychotics Review off-label, nonpsychiatric indications for antidepressants and antipsychotics by way of this case presentation of a woman with abdominal pain and hiccups.
  Current Psychiatry, September 21, 2022
• A Consensus Definition of Recovery in First-episode Psychosis The authors propose criteria for a consensus definition of clinical recovery for first-episode psychosis which would include affective symptom remission and more reasonable criteria for functioning.
  Schizophrenia Bulletin, September 14, 2022
• Reimagining Cholinergic Therapy for Alzheimer's Disease This comprehensive review explores the pathophysiology of the basal forebrain cholinergic system, its relation to cognition, and its relevance for Alzheimer disease therapy.
  Brain, September 09, 2022